Supervivencia a 5 años por estadío clínico de pacientes con cáncer invasivo de estómago diagnosticados en el Instituto del Cáncer SOLCA Loja durante enero 2008 a junio 2009

Abstract

Abstract: The objective of this research is to determine the 5-year survival for clinical stage of patients with invasive cancer of the stomach through characterization and therapeutic management. The study is descriptive, cross-sectional and retrospective, and considers the medical records of 36 patients diagnosed with invasive cancer of the stomach within the prescribed period and who met the inclusion criteria. It could be concluded that patients diagnosed with gastric cancer in stage I and II, have a probability of survival at 5 years 100%, but not in stage III, where the five-year survival is 40%, and the stadium IV, whose probability of survival at 5 years is 4%, therefore it can be said that the five-year survival of patients diagnosed with gastric cancer is inversely proportional to the clinical stage, being higher in stage I and lower in stage IV.